ARTICLE | Financial News
Adamas Pharmaceuticals amends IPO
March 31, 2014 7:00 AM UTC
Adamas Pharmaceuticals Inc., Emeryville, Calif. Business: Neurology, Infectious Date announced: 3/26/14 Type: IPO To be raised: Up to $54 million Shares: 3 million Price: $16-$18 Underwriters: Credit ...